BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27365309)

  • 21. [Caco 2 cell culture as intestinal epithelium model for hexose transport studying].
    Grefner NM; Gromova LV; Gruzdkov AA; Komissarchik IaIu
    Tsitologiia; 2012; 54(4):318-23. PubMed ID: 22724369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
    Olson A; Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CFTR and tight junctions in cultured bronchial epithelial cells.
    Nilsson HE; Dragomir A; Lazorova L; Johannesson M; Roomans GM
    Exp Mol Pathol; 2010 Feb; 88(1):118-27. PubMed ID: 19818767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid Evaluation of Intestinal Paracellular Permeability Using the Human Enterocytic-Like Caco-2/TC7 Cell Line.
    Postal BG; Aguanno D; Thenet S; Carrière V
    Methods Mol Biol; 2021; 2367():13-26. PubMed ID: 33730353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
    Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging relationship between CFTR, actin and tight junction organization in cystic fibrosis airway epithelium.
    Castellani S; Favia M; Guerra L; Carbone A; Abbattiscianni AC; Di Gioia S; Casavola V; Conese M
    Histol Histopathol; 2017 May; 32(5):445-459. PubMed ID: 27834058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
    Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of furazolidone apical-related effects to human polarized intestinal cells.
    De Angelis I; Vincentini O; Brambilla G; Stammati A; Zucco F
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):119-27. PubMed ID: 9772207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation.
    Navabi N; McGuckin MA; Lindén SK
    PLoS One; 2013; 8(7):e68761. PubMed ID: 23869232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells.
    Beutheu S; Ghouzali I; Galas L; Déchelotte P; Coëffier M
    Clin Nutr; 2013 Oct; 32(5):863-9. PubMed ID: 23428392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal protection by phosphatidylcholine.
    Stremmel W; Ehehalt R; Staffer S; Stoffels S; Mohr A; Karner M; Braun A
    Dig Dis; 2012; 30 Suppl 3():85-91. PubMed ID: 23295697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Ussing type chamber model to study the intestinal transport and modulation of specific tight-junction genes using a colonic cell line.
    Bergmann H; Rogoll D; Scheppach W; Melcher R; Richling E
    Mol Nutr Food Res; 2009 Oct; 53(10):1211-25. PubMed ID: 19764065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions.
    Beguin P; Errachid A; Larondelle Y; Schneider YJ
    Food Funct; 2013 Jun; 4(6):923-31. PubMed ID: 23660640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of phosphatidylcholine on gut mucosal surface is not dominated by electrostatic interactions.
    Korytowski A; Abuillan W; Amadei F; Makky A; Gumiero A; Sinning I; Gauss A; Stremmel W; Tanaka M
    Biochim Biophys Acta Biomembr; 2017 May; 1859(5):959-965. PubMed ID: 28212861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of conjugated linoleic acid on transepithelial calcium transport and mediators of paracellular permeability in human intestinal-like Caco-2 cells.
    Jewell C; Cusack S; Cashman KD
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):163-71. PubMed ID: 15664300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for tight junction protein disruption in intestinal mucosa of malignant obstructive jaundice patients.
    Wang N; Yu H; Ma J; Wu W; Zhao D; Shi X; Tian H; Jiang H
    Scand J Gastroenterol; 2010; 45(2):191-9. PubMed ID: 20095884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
    Musch MW; Walsh-Reitz MM; Chang EB
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.
    Ling X; Linglong P; Weixia D; Hong W
    PLoS One; 2016; 11(8):e0161635. PubMed ID: 27551722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro transfer of nitazoxanide across the intestinal epithelial barrier.
    Matysiak-Budnik T; Mégraud F; Heyman M
    J Pharm Pharmacol; 2002 Oct; 54(10):1413-7. PubMed ID: 12396305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.